Physician-Modified Thoracic Stent-Grafts for the Treatment of Aortic Arch Lesions

Autor: Ludovic Canaud, Pierre Alric, Thomas Gandet, Kouhei Narayama, Tsuyoshi Shibata, Baris Ata Ozdemir, Kiyofumi Morishita, Toshio Baba
Přispěvatelé: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hakodate Municipal Hospital, Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Hakodate Municipal Hospital, Hakodate, Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Rok vydání: 2017
Předmět:
Male
Aortic arch
Time Factors
Computed Tomography Angiography
aortic arch
[SDV]Life Sciences [q-bio]
medicine.medical_treatment
Aorta
Thoracic

030204 cardiovascular system & hematology
fenestration
0302 clinical medicine
Japan
physician-modified stent-grafts
030212 general & internal medicine
Aged
80 and over

Endovascular Procedures
endograft
Middle Aged
humanities
3. Good health
surgeon-modified stent-graft
scallop
Treatment Outcome
surgical procedures
operative

dissection
cardiovascular system
Female
France
Cardiology and Cardiovascular Medicine
medicine.medical_specialty
Aortic Diseases
Dissection (medical)
Prosthesis Design
Aortography
thoracic endovascular aortic repair
Blood Vessel Prosthesis Implantation
03 medical and health sciences
Aneurysm
medicine.artery
medicine
Humans
Radiology
Nuclear Medicine and imaging

cardiovascular diseases
Aged
Retrospective Studies
business.industry
Stent
medicine.disease
Blood Vessel Prosthesis
Surgery
aneurysm
Feasibility Studies
business
Fenestration
Zdroj: Journal of endovascular therapy
Journal of endovascular therapy, International Society of Endovascular Specialists, 2017, 24 (4), pp.542--548. ⟨10.1177/1526602817714206⟩
ISSN: 1545-1550
1526-6028
Popis: International audience; To evaluate outcomes of physician-modified thoracic stent-grafts for the treatment of aortic arch aneurysms. METHODS: A retrospective dual-center analysis was performed involving 36 patients (mean age 74.7\textpm9 years, range 58-91; 27 men) with an aortic arch lesion who were treated between November 2013 and June 2016 using physician-modified thoracic stent-grafts. Half of the patients had a degenerative aneurysm; the remainder had type B dissection (n=9), traumatic transection (n=3), type Ia endoleak after previous endografting (n=5), or aortoesophageal fistula (n=1). All patients were considered to be at high surgical risk. Patients were treated using an aortic arch stent-graft with a single fenestration (n=24) or a proximal scallop (n=12); zone 0 was involved in 16 patients, zone 1 in 9, and zone 2 in 11. The modified thoracic stent-graft was deployed after supra-aortic branch revascularization in 24 (67%) patients. RESULTS: Mean time required for stent-graft modifications was 18 minutes (range 14-21). Technical success was obtained in all cases with no type I endoleak. One (3%) patient had a stroke without permanent sequelae. The 30-day mortality was 6%. During a mean follow-up of 11.4\textpm6 months (range 2-36), there were no conversions to open repair. The overall mortality was 14%; aorta-related mortality was 6%. CONCLUSION: Our experience suggests that physician-modified thoracic stent-grafts are feasible for aortic arch lesions and provide encouraging results in the short term. Durability concerns will need to be assessed.
Databáze: OpenAIRE